Salesforce (CRM) director reports 274 shares from RSU vesting

Q: What did Craig Conway report on the Form 4 for Salesforce (CRM)?

Craig Conway reported acquiring 274 shares of Salesforce common stock on 08/22/2025 due to RSU vesting.

Q: How many shares did the reporting person own after the transaction?

8,338 shares of common stock were beneficially owned following the reported transaction.

Q: What was the price paid for the acquired shares on the Form 4?

$0 ; the shares resulted from RSUs that convert one-for-one to common stock.

Q: When did the reported RSUs vest?

Vesting dates listed include 02/22/2025, 05/22/2025, 08/22/2025, and 11/22/2025 with 25% vesting on each date.

Q: Was the Form 4 signed and dated?

Yes. The form shows a signature by Sarah Dale, Attorney-in-Fact for Craig Conway, dated 08/25/2025.

[Form 4] Salesforce, Inc. Insider Trading Activity

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Craig Conway, a director of Salesforce, Inc. (CRM), reported the acquisition of 274 shares of common stock on 08/22/2025. The Form 4 shows the shares resulted from the vesting of 274 restricted stock units (RSUs) that convert one-for-one to common stock and carried a $0 purchase price. The reporting person held 8,338 shares of common stock following the transaction. The filing was signed by an attorney-in-fact on 08/25/2025 and lists the standard RSU vesting schedule showing quarterly vesting dates including 02/22/2025 through 11/22/2025.

Positive

Insider acquisition disclosed transparently with transaction date, amount, and post-transaction holdings clearly stated
RSUs converted one-for-one to common stock at $0, reflecting routine equity compensation vesting

Negative

None.

Insights

TL;DR: Director received 274 shares from RSU vesting; modest insider accumulation with no cash outlay.

The Form 4 documents a routine vesting event where 274 RSUs converted to common stock at no cost to the reporting person. The post-transaction beneficial ownership is 8,338 shares, which is a small, clearly disclosed insider change and does not indicate any market-moving purchase or sale. This is a standard compensation-derived issuance rather than an open-market trade.

TL;DR: Disclosure is complete and follows standard Form 4 requirements for RSU vesting.

The filing provides required details including transaction date, number of shares acquired, resulting beneficial ownership, and the RSU vesting schedule. Signature by an attorney-in-fact is provided. There are no indications of amendments, plans, or sale transactions; the disclosure aligns with routine director compensation reporting obligations.

08/25/2025 - 07:25 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Conway Craig

(Last)

(First)

(Middle)

415 MISSION STREET

3RD FLOOR

(Street)

SAN FRANCISCO

94105

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Salesforce, Inc. [ CRM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/22/2025		M		274	A	$0	8,338	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	$0⁽¹⁾	08/22/2025		M			274	02/22/2025⁽²⁾	11/22/2025	Common Stock	274	$0	274	D

Explanation of Responses:

1. Restricted Stock Units convert to shares of common stock on a one-for-one basis.

2. These restricted stock units vest as to 25% of the original grant on each of February 22, 2025, May 22, 2025, August 22, 2025, and November 22, 2025.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Sarah Dale, Attorney-in-Fact for Craig Conway	08/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What did Craig Conway report on the Form 4 for Salesforce (CRM)?

Craig Conway reported acquiring 274 shares of Salesforce common stock on 08/22/2025 due to RSU vesting.

How many shares did the reporting person own after the transaction?

8,338 shares of common stock were beneficially owned following the reported transaction.

What was the price paid for the acquired shares on the Form 4?

$0; the shares resulted from RSUs that convert one-for-one to common stock.

When did the reported RSUs vest?

Vesting dates listed include 02/22/2025, 05/22/2025, 08/22/2025, and 11/22/2025 with 25% vesting on each date.

Was the Form 4 signed and dated?

Yes. The form shows a signature by Sarah Dale, Attorney-in-Fact for Craig Conway, dated 08/25/2025.

AG真人官方

[Form 4] Salesforce, Inc. Insider Trading Activity

Insights

FAQ

What did Craig Conway report on the Form 4 for Salesforce (CRM)?

How many shares did the reporting person own after the transaction?

What was the price paid for the acquired shares on the Form 4?

When did the reported RSUs vest?

Was the Form 4 signed and dated?

NYSE:CRM

CRM Rankings

CRM Latest News

CRM Latest SEC Filings

CRM Stock Data

AG真人官方

Trending News

[Form 4] Salesforce, Inc. Insider Trading Activity

Insights

Financial Analyst neutral

Corporate Governance Expert neutral

FAQ

What did Craig Conway report on the Form 4 for Salesforce (CRM)?

How many shares did the reporting person own after the transaction?

What was the price paid for the acquired shares on the Form 4?

When did the reported RSUs vest?

Was the Form 4 signed and dated?

NYSE:CRM

CRM Rankings

CRM Latest News

CRM Latest SEC Filings

CRM Stock Data